ľ¹ÏÖ±²¥

Announcements

Dr. Collins welcomed everyone to this special meeting of NIH IC Directors, which was called to provide additional information on the NIH IRP-Pfizer Centers for Therapeutic Innovation.   

NIH IRP-Pfizer Centers for Therapeutic Innovation: Chris Austin

Dr. Austin (NCATS) provided an overview of the proposed collaboration model, governance structure, and evaluation criteria for the joint project with the NIH IRP and the Pfizer Centers for Therapeutic Innovation (CTI). He also summarized the statistics of the selected projects, the advantages to NIH, and the potential logistical issues associated with this collaboration. The discussion focused on the dispute resolution process, the roll-out to the extramural community, status of trainees, potential expansion of the program, publication procedures, and policies for project approval.